Treating Bacterial Overgrowth in Parkinson's Disease
Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
This study investigates the effect of treating Small Intestinal Bacterial Overgrowth (SIBO)
in patients with Parkinson's Disease (PD). It will test the hypothesis that treating SIBO
with the antibiotic rifaximin will improve motor complications in previously SIBO-positive PD
patients.